Latest News- Travel Vaccines Market: Influenza is expected to lead the Disease Type segment during 2025-2029

The Travel Vaccines Market is being driven by Increase in global migration

The Travel Vaccines Market is expected to grow at a CAGR of 10.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 7052.4 million. The demographic profile of travelers significantly influences the success of achieving travel vaccine compliance. Migrants, for instance, represent a population with fewer chances of being vaccinated prior to travel due to various reasons. This trend poses a higher risk of contracting vaccine-preventable diseases upon arrival in the host country. Additionally, the age factor plays a crucial role in travel vaccination uptake. Younger travelers, typically those under 30 years old, are more likely to opt for traveling and seek advice on travel-related vaccinations, thereby increasing their chances of getting immunized. Countries with burgeoning job markets, such as the US, Canada, Germany, Australia, and Singapore, are experiencing an influx of migrants, further emphasizing the importance of addressing this vaccination gap. 

Get more information on Travel Vaccines Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Disease Type
  • Influenza
  • Diptheria
  • Hepatitis
  • Typhoid and others
• End-user
  • Adult vaccines
  • Pediatric vaccines
• Type
  • Outbound
  • Inbound
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase in global migration
• Increase in awareness of vaccine-preventable diseases among travelers
• Mandatory regulations on immunization prior to issuing visas

However, the market also witnesses some limitations, which are as follows:

• Lack of coverage for travel vaccines in health plans
• High cost of travel vaccines
• Delays in regulatory approvals for recommended travel vaccines in certain countries

Benefits of Buying Global Travel Vaccines Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Travel Vaccines Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Travel vaccines play a crucial role in preventing infections and ensuring public health during international travel. By stimulating the immune system with specific vaccine components, travelers can protect themselves from disease vectors and infection prophylaxis for various conditions such as malaria, yellow fever, typhoid fever, hepatitis A, rabies, meningitis, influenza, and Japanese encephalitis. Risk stratification based on travel itinerary and destination-specific diseases is essential for effective vaccine selection. Booster shots and antibody titer tests may be required for continued protection. Vaccine preservation and logistics, immunization registry, health screening, and pandemic preparedness are also crucial aspects of travel medicine. Infection control measures and prophylactic measures are vital in preventing disease outbreaks.

Market Research Overview

The Travel Vaccines Market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development (R&D) or production of travel vaccines. The market's size is determined by the consolidated revenue generated by manufacturers and providers of these vaccines. Factors driving the market's growth include an aging population, with the proportion of individuals aged 60 and above projected to increase significantly in both the US and Europe by 2030-2050. Vaccine efficacy, adverse reactions, immunogenicity studies, and serotype coverage are crucial considerations in the development and adoption of travel vaccines. Technavio's market analysis indicates that the global pharmaceuticals market, which includes equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, will experience substantial growth due to this demographic trend.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/